Which medication reduces the risk of vertebral and hip fractures in osteoporosis by inhibiting osteoclast activity?
Show answer and explanation
Correct answer: Alendronate
Alendronate is a bisphosphonate that inhibits osteoclasts, reducing bone resorption. It reduces both vertebral and hip fracture risk.
Practice all 20 Musculoskeletal and Skin: Osteoporosis, Psoriasis questions
Keep practicing
More Musculoskeletal and Skin: Osteoporosis, Psoriasis questions
- A patient with psoriasis asks about nail findings associated with the disease. Which finding is characteristic?
- A postmenopausal woman begins estrogen replacement therapy. How does estrogen affect bone physiology?
- Which cytokine plays a major role in the pathogenesis of psoriasis?
- A patient presents with vertebral compression fractures. Which lab abnormality is expected in primary osteoporosis?
- A patient with psoriasis is started on a TNF-α inhibitor. What is the major risk of this therapy?
- A 65-year-old woman with osteoporosis begins teriparatide therapy. What is its mechanism?